Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA intends to acquire one Ophthalmic Adaptive Optics Retinal Imaging System for research and regulatory activities. Delivery and installation will occur at the FDA White Oak Campus in Silver Spring, Maryland. Interested bidders should refer to the Combined Synopsis/Solicitation document RFQ-FDA-133666 for complete requirements.
The Food and Drug Administration (FDA), Center for Devices and Radiological Health (CDRH), Office of Science and Engineering Laboratories (OSEL), Division of Biomedical Physics (DBP) intends to acquire one (1) Ophthalmic Adaptive Optics (AO) Retinal Imaging System. The system will be used to support retinal imaging research, biomarker development, and regulatory science activities at the FDA White Oak Campus in Silver Spring, Maryland. Delivery and installation shall be made to 10903 New Hampshire Avenue, Building WO62, Room G101, Silver Spring, MD 20993. For complete requirements, terms, and conditions, please refer to the attached Combined Synopsis/Solicitation (CSS) document No. RFQ-FDA-133666 .
OPHTHALMIC ADAPTIVE OPTICS (AO) RETINAL IMAGING SYSTEM is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.